Merck Halts Sale Of Niacin Drug In 40 Countries. January 11, 2013 10:43 ... Tredaptive was never approved in the U.S. — the Food and Drug Administration rejected the drug under another name in 2008.

Niacin - Trade Names Discover all the brand names or Trade names of generic drug called Niacin. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone ...

Merck's niacin-containing cholesterol drug, sold under the brand name Tredaptive in Europe but still considered experimental here in the U.S., failed to prevent heart attacks, strokes, and heart ...

An experimental Merck drug using the B vitamin niacin shows potential as a cholesterol reducer.

Prompted by that study, leaders of an earlier one that tested a different niacin drug, Niaspan, re-examined side effects among their 3,414 participants and detailed them in a letter in the medical ...

Although it is touted on the Internet as a way to beat a drug test, taking large doses of the over-the-counter supplement niacin, also known as vitamin B3, is both ineffective and potentially dange… ...

Niacin users’ main complaint has been flushing, so drug companies have been testing extended-release formulations and combining other medicines with it to minimize that problem.

A large niacin-plus-simvistatin study by the drug maker Merck may have far-reaching implications, since millions of people take niacin every day to prevent heart attacks and strokes. One doctor ...

PHILADELPHIA -- Those who try to foil urine drug tests with massive doses of niacin -- it doesn't work -- may wind up in a hospital emergency department.

A large, international study found the drug did not reduce the risk of heart disease and stroke, yet did trigger some serious side effects. Merck Halts Sale Of Niacin Drug In 40 Countries | KCUR ...

Drugmaker Merck just stuck a fork in a vitamin-based drug to prevent heart disease and stroke. The company is withdrawing Tredaptive, a long-acting pill combining niacin (No. 3 in the long list of B ...